The AIDS Reader: AIDS and HIV News and Information
A recent study published in the New England Journal of Medicine examines the optimal timing of starting antiretroviral therapy in patients with cryptococcal meningitis. Details here.
Despite gains, the sobering reality is that HIV transmission-- primarily via sexual means--continues at an unacceptably high rate in the United States.
Now that HIV infection is largely a chronic disease, cardiovascular disease has become a leading cause of death in this patient group. Here: a look at just how common LDL-C dyslipidemia, hypertension, and coronary heart disease really are.
The flu vaccine effectively prevents influenza in pregnant women, regardless of whether they are HIV positive, according to a new study. Results offer clinicians greater assurance to vaccinate all pregnant woman.
A once daily MVC plus DRV/r regimen had an effective role in antiretroviral drug-pretreated individuals with controlled HIV infection in this trial. In an aging HIV-infected population, with increasing comorbidities, this combination could be a safer option than standard triple therapy. More here.
It now seems probable that most people with HCV infection can be cured—even if they are co-infected with HIV. But the "cost" of cure is expensive. This author concludes that many new regimens are cost effective and should not be withheld or made difficult to obtain by insurance companies and other payors.
Antiretroviral treatment does not appear to affect a woman's ability to become pregnant or to adversely affect fetal outcomes, according to this study.
(AUDIO) Now that HIV testing is universally mandated, what are the best ways to reach into a community to find those who remain untested? In this brief recorded interview, the head of a study designed to test two approaches describes why either one is better than the status quo.
(AUDIO) In a brief podcast, the director of the University of North Carolina infectious diseases center ponders the implications of new HIV strains that lead to AIDS symptoms significantly faster than in the past. To him, the response is obvious. What troubles him is that not everyone seems to sense the urgency
(AUDIO) The past year has been revolutionary for HIV-positive patients, both in medical care and in policy. And more is in store for the coming year, according to Dr. Michael Horberg of Kaiser Permanente. Listen as the immediate past president of the HIV Medicine Association briefly reviews events of 2013 and forecasts 2014.
(AUDIO) Now that guidelines mandate testing all adults for HIV status, what are the best ways to convey the results of this important but often sensitive test? Listen as the co-director of Emory University's Center for AIDS Research offers insights for effective communication on this topic.